Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H21ClN6O |
InChIKeyXQPFDQVEBGYLHB-UHFFFAOYSA-N |
CAS Registry885500-12-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 12 Feb 2010 |